Oragenics Stock Analysis
OGEN Stock | USD 1.08 0.14 11.48% |
Oragenics is undervalued with Real Value of 23.3 and Target Price of 90.0. The main objective of Oragenics stock analysis is to determine its intrinsic value, which is an estimate of what Oragenics is worth, separate from its market price. There are two main types of Oragenics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Oragenics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Oragenics' stock to identify patterns and trends that may indicate its future price movements.
The Oragenics stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Oragenics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Oragenics Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Oragenics' ongoing operational relationships across important fundamental and technical indicators.
Oragenics |
Oragenics Stock Analysis Notes
About 23.0% of the company outstanding shares are owned by corporate insiders. The book value of Oragenics was now reported as 0.51. The company recorded a loss per share of 9.18. Oragenics last dividend was issued on the 22nd of January 2018. The entity had 1:60 split on the 23rd of January 2023. Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida. Oragenics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people. To find out more about Oragenics contact Alan Joslyn at 813 286 7900 or learn more at https://www.oragenics.com.Oragenics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Oragenics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Oragenics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Oragenics generated a negative expected return over the last 90 days | |
Oragenics has high historical volatility and very poor performance | |
Oragenics has some characteristics of a very speculative penny stock | |
Oragenics has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 131.52 K. Net Loss for the year was (20.66 M) with loss before overhead, payroll, taxes, and interest of (9.94 M). | |
Oragenics currently holds about 17.87 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15. | |
Oragenics has a frail financial position based on the latest SEC disclosures | |
Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from news.google.com: Oragenics Coverage Initiated by Analysts at StockNews.com - Defense World |
Oragenics Upcoming and Recent Events
Earnings reports are used by Oragenics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Oragenics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
17th of April 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Oragenics Largest EPS Surprises
Earnings surprises can significantly impact Oragenics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2018-11-13 | 2018-09-30 | -0.29 | -0.35 | -0.06 | 20 | ||
2018-08-13 | 2018-06-30 | -0.45 | -0.38 | 0.07 | 15 | ||
2021-05-03 | 2021-03-31 | -2.7 | -3.0 | -0.3 | 11 |
Oragenics Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oragenics's market, we take the total number of its shares issued and multiply it by Oragenics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Oragenics Profitablity
Oragenics' profitability indicators refer to fundamental financial ratios that showcase Oragenics' ability to generate income relative to its revenue or operating costs. If, let's say, Oragenics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Oragenics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Oragenics' profitability requires more research than a typical breakdown of Oragenics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (4.16) | (3.95) | |
Return On Capital Employed | (3.37) | (3.54) | |
Return On Assets | (4.16) | (3.95) | |
Return On Equity | (6.52) | (6.19) |
Management Efficiency
Oragenics has return on total asset (ROA) of (1.3248) % which means that it has lost $1.3248 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.5536) %, meaning that it created substantial loss on money invested by shareholders. Oragenics' management efficiency ratios could be used to measure how well Oragenics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of April 2024, Return On Tangible Assets is likely to grow to -3.95. In addition to that, Return On Capital Employed is likely to drop to -3.54. At this time, Oragenics' Total Assets are very stable compared to the past year. As of the 18th of April 2024, Non Current Assets Total is likely to grow to about 1.2 M, while Total Current Assets are likely to drop about 3.7 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.41 | 1.34 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 1.41 | 1.34 | |
Enterprise Value Over EBITDA | (0.89) | (0.94) | |
Price Book Value Ratio | 4.00 | 2.87 | |
Enterprise Value Multiple | (0.89) | (0.94) | |
Price Fair Value | 4.00 | 2.87 | |
Enterprise Value | 9.5 M | 18 M |
The analysis of Oragenics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Oragenics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Oragenics Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.323 |
Technical Drivers
As of the 18th of April 2024, Oragenics holds the Variance of 100.85, coefficient of variation of (511.08), and Risk Adjusted Performance of (0.11). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oragenics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Oragenics, which can be compared to its competitors. Please check Oragenics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Oragenics is priced some-what accurately, providing market reflects its current price of 1.08 per share. Given that Oragenics is a hitting penny stock territory we advise to closely look at its jensen alpha.Oragenics Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Oragenics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Oragenics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Oragenics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Oragenics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Oragenics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Oragenics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Telling Fred over three months ago Sale by Telling Fred of 3500 shares of Oragenics | ||
Charles Pope over six months ago Acquisition by Charles Pope of 25000 shares of Oragenics subject to Rule 16b-3 | ||
Telling Fred over six months ago Purchase by Telling Fred of 6460 shares of Oragenics | ||
Telling Fred over six months ago Acquisition by Telling Fred of 4000 shares of Oragenics subject to Rule 16b-3 |
Oragenics Predictive Daily Indicators
Oragenics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Oragenics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Oragenics Forecast Models
Oragenics' time-series forecasting models are one of many Oragenics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oragenics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Oragenics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Oragenics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oragenics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oragenics. By using and applying Oragenics Stock analysis, traders can create a robust methodology for identifying Oragenics entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (124.94) | (118.69) | |
Operating Profit Margin | (126.05) | (119.75) | |
Net Loss | (123.82) | (117.63) | |
Gross Profit Margin | 0.76 | 0.64 |
Current Oragenics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Oragenics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Oragenics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
90.0 | Strong Buy | 1 | Odds |
Most Oragenics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Oragenics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Oragenics, talking to its executives and customers, or listening to Oragenics conference calls.
Oragenics Stock Analysis Indicators
Oragenics stock analysis indicators help investors evaluate how Oragenics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Oragenics shares will generate the highest return on investment. By understating and applying Oragenics stock analysis, traders can identify Oragenics position entry and exit signals to maximize returns.
Begin Period Cash Flow | 11.4 M | |
Common Stock Shares Outstanding | 2.2 M | |
Total Stockholder Equity | 3.2 M | |
Property Plant And Equipment Net | 9811.00 | |
Cash And Short Term Investments | 3.5 M | |
Cash | 3.5 M | |
Accounts Payable | 1.2 M | |
Net Debt | -3.2 M | |
50 Day M A | 1.985 | |
Total Current Liabilities | 1.8 M | |
Other Operating Expenses | 10.7 M | |
Non Current Assets Total | 1.1 M | |
Non Currrent Assets Other | 1.1 M | |
Stock Based Compensation | 1 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.Note that the Oragenics information on this page should be used as a complementary analysis to other Oragenics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Oragenics Stock analysis
When running Oragenics' price analysis, check to measure Oragenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oragenics is operating at the current time. Most of Oragenics' value examination focuses on studying past and present price action to predict the probability of Oragenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oragenics' price. Additionally, you may evaluate how the addition of Oragenics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Oragenics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.18) | Revenue Per Share 0.017 | Quarterly Revenue Growth (0.91) | Return On Assets (1.32) | Return On Equity (2.55) |
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.